Project Grant R01DC021434

Award Date 5/1/25
Completion Date 4/30/30
Dollars Obligated $620K
Federal Grant Program
93.173
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $651,779 Project Grant under the Research Related to Deafness and Communication Disorders federal grant program (CFDA 93.173) to the Massachusetts Eye and Ear Infirmary. The purpose of this 5-year project is to investigate the effects of a vestibular implant (VI) on improving spatial orientation, navigation, and neuropsychological function in patients with severe bilateral vestibular loss. The research team...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will provide $589,483 to Wayne State University to investigate the impact of peripheral vestibular nerve injury on central neuronal activation and synaptic transmission in the vestibular system. The research aims to evaluate how noise-induced vestibular nerve hypofunction affects motor function and...
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $192,056 Project Grant to the University of Chicago for the project "Spatiotemporal Models of Neural Coding in the Vestibular Periphery". This research aims to develop circuit-level computational models of the vestibular periphery, including hair cells, afferent neurons, and efferent feedback, to better understand how the spatial organization and biophysical properties of this system influence neural...
This $514,546 federal Project Grant awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) aims to improve diagnosis and treatment of complex forms of benign paroxysmal positional vertigo (BPPV) and related labyrinth disorders. The 5-year project, running from Apr 1, 2025 to Mar 31, 2030, will: 1) quantify variance in human labyrinth morphology to inform robust canalith...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $690,404 to the University of Washington to investigate mechanisms that promote the development and maintenance of specialized hair cell and synaptic structures in the vestibular system. The goal is to generate new fundamental knowledge about how vestibular hair cells establish and...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides funding for research to investigate how peripheral vestibular signals create vestibular compound action potentials. The primary focus is on understanding the mechanisms underlying the generation of vestibular compound action potentials, which are critical for diagnosing and treating...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (CFDA 93.173 - Research Related to Deafness and Communication Disorders) in the amount of $828,022 will support research to characterize nonlinear response properties and effects of aging on vestibular reflexes in humans. The award will enable novel electrophysiological investigations to identify, for the first time, nonlinearity in cervical and ocular vestibular evoked myogenic...
This Project Grant award, with a total funding amount of $632,334.00 and an award date of September 1, 2024, is provided by the National Institute on Aging (CFDA 93.866 Aging Research) to the Massachusetts Eye and Ear Infirmary. The grant supports a comprehensive research study investigating the contributions of vestibular dysfunction, sensory integration, and central processing deficits to balance impairment and fall risk in older adults. The project aims to develop a holistic understanding...
This Project Grant award, with a total funding amount of $265,410.00, was provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The grant was awarded on December 17, 2024 and is scheduled for completion by November 30, 2025. The award supports research by The Children's Hospital Corporation, doing business as Boston Children's Hospital, to investigate how the heterogeneous...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders Federal Grant Program (CFDA 93.173), provides $194,400.00 to the Massachusetts Eye and Ear Infirmary to investigate the role of the PHEX signaling pathway in the development of a Meniere's disease subtype characterized by endolymphatic sac hypoplasia. The project aims to establish the genetic and phenotypic links between...

This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will provide $620,240 from May 1, 2025 to April 30, 2030 to the Massachusetts Eye and Ear Infirmary. The purpose of the award is to conduct an observational study examining vestibular pathophysiology and the vestibular implications of standard interventions (surgery, chemotherapy, radiation therapy) in patients with sporadic vestibular schwannomas (SVS) and neurofibromatosis type 2-related schwannomatosis (NF2/VS). The study will analyze vestibular function, clinical vestibular disability, and non-vestibular parameters to better understand the relationship between vestibular dysfunction and patient outcomes. The findings are expected to provide insights into the underlying pathophysiology of vestibular dysfunction in these patient populations and guide treatment strategies.

Generated 5/13/25, 4:53 AM